COMPANY OVERVIEW

RDD is a privately held specialty pharma company, backed by Orbimed. RDD focuses on fast-track development and commercialization of innovative therapeutics for anorectal diseases and gastrointestinal disorders.

---

LOCATION

New York, NY, USA

Tel-Aviv, , Israel

---

THERAPEUTIC AREAS

Gastrointestinal Disease

---

WEBSITE

https://www.rddpharma.com/

---

CAREER WEBSITE

None

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Nov 13, 2019

RDD Pharma Enters into Non-Binding Letter of Intent to Acquire Naia Rare Diseases, Strengthening Gastroenterology Orphan Disease Pipeline

Mar 18, 2019

RDD Pharma Appoints John Temperato as Chief Executive Officer

Feb 14, 2019

RDD Pharma Receives Fast Track Designation from FDA for RDD-0315 for Treatment of Fecal Incontinence in Spinal Cord Injury Patients

Jul 17, 2018

RDD Pharma Announces IND Clearance to Advance RDD-0315 to Treat Fecal Incontinence in Patients with Spinal Cord Injury

Jun 4, 2018

RDD Pharma Appoints Dr. Mark Sirgo as Board Chairman

For More Press Releases

---